[Federal Register Volume 82, Number 102 (Tuesday, May 30, 2017)]
[Notices]
[Pages 24745-24746]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-11027]
-----------------------------------------------------------------------
NUCLEAR REGULATORY COMMISSION
[NRC-2017-0094]
Patient Release Program
AGENCY: Nuclear Regulatory Commission.
ACTION: Extension of comment period.
-----------------------------------------------------------------------
SUMMARY: On April 11, 2017, the U.S. Nuclear Regulatory Commission
(NRC) solicited comments on its patient release program. The public
comment period was originally scheduled to close on June 12, 2017. The
NRC has decided to extend the public comment period to allow more time
for members of the public to develop and submit their comments.
DATES: The due date of comments requested in the document published on
April 11, 2017 (82 FR 17465), is extended. Comments should be filed no
later than June 27, 2017. Comments received after this date will be
considered, if it is practical to do so, but the NRC is able to ensure
consideration only for comments received on or before this date.
ADDRESSES: You may submit comments by any of the following methods
(unless this document describes a different method for submitting
comments on a specific subject):
Federal Rulemaking Web site: Go to http://www.regulations.gov and search for Docket ID NRC-2017-0094. Address
questions about NRC dockets to Carol Gallagher; telephone: 301-415-
3463; email: [email protected]. For technical questions, contact
the individual listed in the FOR FURTHER INFORMATION CONTACT section of
this document.
Mail comments to: Cindy Bladey, Office of Administration,
Mail Stop: TWFN-8-D36M, U.S. Nuclear Regulatory Commission, Washington,
DC 20555-0001.
For additional direction on obtaining information and submitting
comments, see ``Obtaining Information and Submitting Comments'' in the
SUPPLEMENTARY INFORMATION section of this document.
FOR FURTHER INFORMATION CONTACT: Donna-Beth Howe, Office of Nuclear
Material Safety and Safeguards, U.S. Nuclear Regulatory Commission,
Washington, DC 20555-0001; telephone: 301-415-7848; email: [email protected].
SUPPLEMENTARY INFORMATION:
I. Obtaining Information and Submitting Comments
A. Obtaining Information
Please refer to Docket ID NRC-2017-0094 when contacting the NRC
about the availability of information for this action. You may obtain
publicly-available information related to this action by any of the
following methods:
Federal Rulemaking Web site: Go to http://www.regulations.gov and search for Docket ID NRC-2017-0094.
NRC's Agencywide Documents Access and Management System
(ADAMS): You may obtain publicly-available documents online in the
ADAMS Public Documents collection at http://www.nrc.gov/reading-rm/adams.html. To begin the search, select ``ADAMS Public Documents'' and
then select ``Begin Web-based ADAMS Search.'' For problems with ADAMS,
please contact the NRC's Public Document Room (PDR) reference staff at
1-800-397-4209, 301-415-4737, or by email to [email protected]. The
ADAMS accession number for each document referenced (if it is available
in ADAMS) is provided the first time that it is mentioned in the
SUPPLEMENTARY INFORMATION section.
NRC's PDR: You may examine and purchase copies of public
documents at the NRC's PDR, Room O1-F21, One White Flint North, 11555
Rockville Pike, Rockville, Maryland 20852.
B. Submitting Comments
Please include Docket ID NRC-2017-0094 in your submission.
The NRC cautions you not to include identifying or contact
information that you do not want to be publicly disclosed in your
comment submission. The NRC posts all comment submissions at http://www.regulations.gov as well as entering the comment submissions into
ADAMS. The NRC does not routinely edit comment submissions to remove
identifying or contact information.
If you are requesting or aggregating comments from other persons
for submission to the NRC, then you should inform those persons not to
include identifying or contact information that they do not want to be
publicly
[[Page 24746]]
disclosed in their comment submission. Your request should state that
the NRC does not routinely edit comment submissions to remove such
information before making the comment submissions available to the
public or entering the comment submissions into ADAMS.
II. Discussion
On April 11, 2017, the NRC solicited comments on its patient
release program. The purpose of requesting information from the general
public on its patient release program was to receive input from the
public on whether additional or alternate criteria are needed and
whether to clarify NRC's current patient release criteria. The
information collected will be used to determine whether significant
regulatory changes to NRC's patient release program are warranted. The
public comment period was originally scheduled to close on June 12,
2017. The NRC has decided to extend the public comment period on this
document until June 27, 2017, to allow more time for members of the
public to submit their comments.
Dated at Rockville, Maryland, this 24th day of May 2017.
For the Nuclear Regulatory Commission.
Daniel S. Collins,
Director, Division of Material Safety, State, Tribal and Rulemaking
Programs, Office of Nuclear Material Safety and Safeguards.
[FR Doc. 2017-11027 Filed 5-26-17; 8:45 am]
BILLING CODE 7590-01-P